Literature DB >> 18603020

Induction of intrachromosomal homologous recombination in human cells by raltitrexed, an inhibitor of thymidylate synthase.

Barbara Criscuolo Waldman1, Yibin Wang, Kasturi Kilaru, Zhengguan Yang, Alaukik Bhasin, Michael D Wyatt, Alan S Waldman.   

Abstract

Thymidylate deprivation brings about "thymineless death" in prokaryotes and eukaryotes. Although the precise mechanism for thymineless death has remained elusive, inhibition of the enzyme thymidylate synthase (TS), which catalyzes the de novo synthesis of TMP, has served for many years as a basis for chemotherapeutic strategies. Numerous studies have identified a variety of cellular responses to thymidylate deprivation, including disruption of DNA replication and induction of DNA breaks. Since stalled or collapsed replication forks and strand breaks are generally viewed as being recombinogenic, it is not surprising that a link has been demonstrated between recombination induction and thymidylate deprivation in bacteria and lower eukaryotes. A similar connection between recombination and TS inhibition has been suggested by studies done in mammalian cells, but the relationship between recombination and TS inhibition in mammalian cells had not been demonstrated rigorously. To gain insight into the mechanism of thymineless death in mammalian cells, in this work we undertook a direct investigation of recombination in human cells treated with raltitrexed (RTX), a folate analog that is a specific inhibitor of TS. Using a model system to study intrachromosomal homologous recombination in cultured fibroblasts, we provide definitive evidence that treatment with RTX can stimulate accurate recombination events in human cells. Gene conversions not associated with crossovers were specifically enhanced several-fold by RTX. Additional experiments demonstrated that recombination events provoked by a double-strand break (DSB) were not impacted by treatment with RTX, nor was error-prone DSB repair via nonhomologous end-joining. Our work provides evidence that thymineless death in human cells is not mediated by corruption of DSB repair processes and suggests that an increase in chromosomal recombination may be an important element of cellular responses leading to thymineless death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603020      PMCID: PMC2586641          DOI: 10.1016/j.dnarep.2008.06.006

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  36 in total

1.  DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.

Authors:  S I Matsui; M A Arredondo; C Wrzosek; Y M Rustum
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

2.  Raltitrexed increases tumorigenesis as a single agent yet exhibits anti-tumor synergy with 5-fluorouracil in ApcMin/+ mice.

Authors:  John T Murphy; Jody M Tucker; Celestia Davis; Franklin G Berger
Journal:  Cancer Biol Ther       Date:  2004-11-02       Impact factor: 4.742

3.  Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis.

Authors:  J L Tonkinson; P Marder; S L Andis; R M Schultz; L S Gossett; C Shih; L G Mendelsohn
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

4.  Induction of intrachromosomal recombination in yeast by inhibition of thymidylate biosynthesis.

Authors:  B A Kunz; G R Taylor; R H Haynes
Journal:  Genetics       Date:  1986-10       Impact factor: 4.562

5.  Induction of mitotic recombination in yeast by starvation for thymine nucleotides.

Authors:  B A Kunz; B J Barclay; J C Game; J G Little; R H Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.

Authors:  A L Jackman; G A Taylor; W Gibson; R Kimbell; M Brown; A H Calvert; I R Judson; L R Hughes
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

7.  Thymidylate stress induces homologous recombination activity in mammalian cells.

Authors:  Y Mishina; D Ayusawa; T Seno; H Koyama
Journal:  Mutat Res       Date:  1991-01       Impact factor: 2.433

8.  Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death.

Authors:  J A Houghton; D M Tillman; F G Harwood
Journal:  Clin Cancer Res       Date:  1995-07       Impact factor: 12.531

Review 9.  Thymineless death and genetic events in mammalian cells.

Authors:  T Seno; D Ayusawa; K Shimizu; H Koyama; K Takeishi; T Hori
Journal:  Basic Life Sci       Date:  1985

10.  Involvement of base excision repair in response to therapy targeted at thymidylate synthase.

Authors:  Li Li; Sondra H Berger; Michael D Wyatt
Journal:  Mol Cancer Ther       Date:  2004-06       Impact factor: 6.261

View more
  10 in total

1.  Depletion of the bloom syndrome helicase stimulates homology-dependent repair at double-strand breaks in human chromosomes.

Authors:  Yibin Wang; Krissy Smith; Barbara Criscuolo Waldman; Alan S Waldman
Journal:  DNA Repair (Amst)       Date:  2011-04-03

Review 2.  Oligo/polynucleotide-based gene modification: strategies and therapeutic potential.

Authors:  R Geoffrey Sargent; Soya Kim; Dieter C Gruenert
Journal:  Oligonucleotides       Date:  2011-03-21

3.  Expression and regulation of RAD51 mediate cellular responses to chemotherapeutics.

Authors:  Zhengguan Yang; Alan S Waldman; Michael D Wyatt
Journal:  Biochem Pharmacol       Date:  2011-12-24       Impact factor: 5.858

4.  SMUG1 but not UNG DNA glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication stress.

Authors:  Pratik Nagaria; David Svilar; Ashley R Brown; Xiao-Hong Wang; Robert W Sobol; Michael D Wyatt
Journal:  Mutat Res       Date:  2012-12-17       Impact factor: 2.433

5.  Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity.

Authors:  Fabricio G Sousa; Renata Matuo; Sai-Wen Tang; Vinodh N Rajapakse; Augustin Luna; Chris Sander; Sudhir Varma; Paul H G Simon; James H Doroshow; William C Reinhold; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2015-02-11

6.  Raltitrexed's effect on the development of neural tube defects in mice is associated with DNA damage, apoptosis, and proliferation.

Authors:  Yanting Dong; Xiuwei Wang; Jianlin Zhang; Zhen Guan; Lin Xu; Jianhua Wang; Ting Zhang; Bo Niu
Journal:  Mol Cell Biochem       Date:  2014-09-23       Impact factor: 3.396

7.  DNA damage and homologous recombination signaling induced by thymidylate deprivation.

Authors:  Zhengguan Yang; Alan S Waldman; Michael D Wyatt
Journal:  Biochem Pharmacol       Date:  2008-08-19       Impact factor: 5.858

8.  Alteration of genetic recombination and double-strand break repair in human cells by progerin expression.

Authors:  Celina J Komari; Anne O Guttman; Shelby R Carr; Taylor L Trachtenberg; Elise A Orloff; Ashley V Haas; Andrew R Patrick; Sona Chowdhary; Barbara C Waldman; Alan S Waldman
Journal:  DNA Repair (Amst)       Date:  2020-09-28

9.  Uracil DNA glycosylase (UNG) loss enhances DNA double strand break formation in human cancer cells exposed to pemetrexed.

Authors:  L D Weeks; G E Zentner; P C Scacheri; S L Gerson
Journal:  Cell Death Dis       Date:  2014-02-06       Impact factor: 8.469

10.  Discovery of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) phenylurea-based thymidylate synthase (TS) inhibitor as a novel multi-effects antitumor drugs with minimal toxicity.

Authors:  Xin-Yang Li; Ting-Jian Zhang; Mohamed Olounfeh Kamara; Guo-Qing Lu; Hai-Li Xu; De-Pu Wang; Fan-Hao Meng
Journal:  Cell Death Dis       Date:  2019-07-11       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.